US 10,820,880

Application 15/337,288 · Granted Nov 3, 2020

Method and apparatus for sensitivity calibration

Estimated expiration

April 13, 2037

10y 145d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jun 6, 2014
+ 20 years
Jun 6, 2034
PTA +1042d
Apr 13, 2037
No TD
—
Final
Apr 13, 2037

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
October 28, 2016
Earliest effective filing
June 6, 2014
Issue date
November 3, 2020
PTA
+1042 days
Base expiry (before PTA)
June 6, 2034

June 6, 2014 + 20 years = June 6, 2034 + 1042 PTA days = April 13, 2037

  • Divisional of application 14/297,709, filed Jun 6, 2014, issued as US 9,504,431
  • PRO61/834,626 — Provisional — not used for base term
  • PRO61/834,626 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/337,288 · US 10,820,880

PatentReply compiles the prosecution history behind US 10,820,880: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US10820880

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.